Contineum Therapeutics Inc

CTNMNASDAQ · USD
9.67USD0.00 (-1.93%)
325

Contineum Therapeutics Inc (CTNM) Option Chain

Read more

Tracking the CTNM option chain helps you see every strike and expiry on Contineum Therapeutics Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CTNM options activity at a glance. Use our scanner to monitor the CTNM option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CTNM stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where CTNM options are being actively traded, and where they are not.

Contineum Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on discovering and developing novel oral small molecule therapies for neuroscience, inflammation, and immunology indications with high unmet need. Its lead asset is PIPE-791, a novel, brain penetrant, small molecule inhibitor of the lysophosphatidic acid 1 receptor (LPA1R) for the treatment of idiopathic pulmonary fibrosis and progressive multiple sclerosis (MS). The company also develops PIPE-307, a novel, small molecule selective inhibitor of the muscarinic type 1 M1 receptor to treat depression and relapse remitting MS; and CTX-343, a peripherally-restricted LPA1R antagonist.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
0.05000.084.672.507.005.00-49.29—0.150.000.15010699.95
10.23580-0.122.170.203.907.50-23.94—0.050.000.05026189.77
56.6217701.150.00—1.1510.00+1.420.101.200.330.3265443.38
89.972003.800.00—3.8012.50+26.770.904.902.830.07036310.03
98.5736000.250.00—0.2515.00+52.133.007.505.33-0.080621.43

As of Nov 16, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $1,503. Ending soon.See the Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank30.95% Moderate
  • Market cap (M$)380
  • 52 weeks high-45.61%
  • 52 weeks low43.90%
  • Analyst recommendationStrong Buy
    1.50
  • Target price$21.43
    121.61% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-03
  • P/E—
  • Future P/E—
  • EPS (ttm)-1.77
  • EPS growth next 5 years2.24%

As of Nov 16, 2026